home / stock / verv / verv short
Short Information | Verve Therapeutics Inc. (NASDAQ:VERV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,017,719 |
Total Actual Volume | 23,295,868 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 150,886 |
Average Short Percentage | 14.23% |
Is there a VERV Short Squeeze or Breakout about to happen?
See the VERV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-27-2024 | $12.98 | $13.19 | $13.24 | $12.65 | 633,399 | 89,258 | 14.09% |
03-26-2024 | $13.28 | $12.79 | $13.43 | $12.77 | 663,926 | 82,860 | 12.48% |
03-25-2024 | $13.04 | $13.16 | $13.23 | $12.8 | 524,540 | 118,410 | 22.57% |
03-22-2024 | $13.21 | $12.97 | $13.238 | $12.8 | 584,667 | 71,275 | 12.19% |
03-21-2024 | $13.61 | $13.21 | $14.2614 | $13.0472 | 889,195 | 123,395 | 13.88% |
03-20-2024 | $12.95 | $13.38 | $13.54 | $12.67 | 780,794 | 114,899 | 14.72% |
03-19-2024 | $13.16 | $13.01 | $13.48 | $12.89 | 870,853 | 85,511 | 9.82% |
03-18-2024 | $13.84 | $13.31 | $13.84 | $12.82 | 878,201 | 102,729 | 11.7% |
03-15-2024 | $13.54 | $13.81 | $14.03 | $13.46 | 4,714,695 | 214,667 | 4.55% |
03-14-2024 | $14.18 | $13.6 | $14.3 | $13.39 | 971,104 | 103,017 | 10.61% |
03-13-2024 | $13.85 | $14.34 | $14.51 | $13.85 | 950,730 | 113,921 | 11.98% |
03-12-2024 | $14.57 | $13.92 | $14.57 | $13.6 | 1,070,138 | 192,369 | 17.98% |
03-11-2024 | $14.99 | $14.42 | $15.55 | $14.23 | 877,667 | 121,868 | 13.89% |
03-08-2024 | $15.37 | $14.96 | $16.03 | $14.7229 | 644,871 | 85,943 | 13.33% |
03-07-2024 | $15.21 | $14.94 | $15.81 | $14.91 | 937,533 | 193,262 | 20.61% |
03-06-2024 | $15.42 | $15.07 | $15.6246 | $14.92 | 1,185,075 | 170,585 | 14.39% |
03-05-2024 | $15.66 | $15.14 | $16.05 | $14.84 | 1,113,909 | 139,437 | 12.52% |
03-04-2024 | $16.4 | $15.84 | $16.5 | $15.37 | 1,312,730 | 218,654 | 16.66% |
03-01-2024 | $17.05 | $16.29 | $17.33 | $16.15 | 1,810,553 | 344,019 | 19% |
02-29-2024 | $18.96 | $17.05 | $19.34 | $16.89 | 1,881,288 | 331,640 | 17.63% |
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on February 29, 2024, the company granted equity awards to thr...
Three Clinical Stage Programs Targeting PCSK9 and ANGPTL3 Expected in 2024 Announced First Human Proof-of-Concept Data for In Vivo Base Editing from Ongoing Heart-1 Phase 1b Clinical Trial of VERVE-101 in November 2023 Cash, Cash Equivalents and Marketable Securities of $624...
BOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of ca...